KH 7

Selective soluble adenylyl cyclase inhibitor CAS# 330676-02-3

KH 7

2D Structure

Catalog No. BCC7787----Order now to get a substantial discount!

Product Name & Size Price Stock
KH 7: 5mg $92 In Stock
KH 7: 10mg Please Inquire In Stock
KH 7: 20mg Please Inquire Please Inquire
KH 7: 50mg Please Inquire Please Inquire
KH 7: 100mg Please Inquire Please Inquire
KH 7: 200mg Please Inquire Please Inquire
KH 7: 500mg Please Inquire Please Inquire
KH 7: 1000mg Please Inquire Please Inquire
Related Products
  • PF-4981517

    Catalog No.:BCC2270
    CAS No.:1390637-82-7
  • Abiraterone

    Catalog No.:BCC2259
    CAS No.:154229-19-3
  • Avasimibe

    Catalog No.:BCC2274
    CAS No.:166518-60-1
  • Alizarin

    Catalog No.:BCN3479
    CAS No.:72-48-0

Quality Control of KH 7

3D structure

Package In Stock

KH 7

Number of papers citing our products

Chemical Properties of KH 7

Cas No. 330676-02-3 SDF Download SDF
PubChem ID 6843191 Appearance Powder
Formula C17H15BrN4O2S M.Wt 419.3
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 100 mg/mL (238.49 mM)
H2O : < 0.1 mg/mL (insoluble)
*"≥" means soluble, but saturation unknown.
Chemical Name 2-(1H-benzimidazol-2-ylsulfanyl)-N'-[(3-bromo-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]propanehydrazide
SMILES CC(C(=O)NNC=C1C=C(C=CC1=O)Br)SC2=NC3=CC=CC=C3N2
Standard InChIKey GEHVZUUHMWNMAY-UHFFFAOYSA-N
Standard InChI InChI=1S/C17H15BrN4O2S/c1-10(25-17-20-13-4-2-3-5-14(13)21-17)16(24)22-19-9-11-8-12(18)6-7-15(11)23/h2-10,19H,1H3,(H,20,21)(H,22,24)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of KH 7

DescriptionSelective soluble adenylyl cyclase (sAC) inhibitor (IC50 = 3 - 10 μM in vivo). Inert towards transmembrane adenylyl cyclase (tmAC) in vitro and in whole cells at concentrations up to 300 μM. Blocks synthesis of cAMP and displays an antiapoptotic effect at concentrations of 1 - 100 μM.

KH 7 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

KH 7 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of KH 7

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.3849 mL 11.9246 mL 23.8493 mL 47.6985 mL 59.6232 mL
5 mM 0.477 mL 2.3849 mL 4.7699 mL 9.5397 mL 11.9246 mL
10 mM 0.2385 mL 1.1925 mL 2.3849 mL 4.7699 mL 5.9623 mL
50 mM 0.0477 mL 0.2385 mL 0.477 mL 0.954 mL 1.1925 mL
100 mM 0.0238 mL 0.1192 mL 0.2385 mL 0.477 mL 0.5962 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
  • Paclitaxel

    Catalog No.:BCN4650
    CAS No.:33069-62-4
  • Avanafil

    Catalog No.:BCC2288
    CAS No.:330784-47-9
  • PCI 29732

    Catalog No.:BCC4100
    CAS No.:330786-25-9
  • MRT 10

    Catalog No.:BCC7950
    CAS No.:330829-30-6
  • Amitraz

    Catalog No.:BCC8816
    CAS No.:33089-61-1
  • Betrixaban

    Catalog No.:BCC5118
    CAS No.:330942-05-7
  • AS 1269574

    Catalog No.:BCC7878
    CAS No.:330981-72-1
  • Caffeic acid

    Catalog No.:BCN5979
    CAS No.:331-39-5
  • IQ 1

    Catalog No.:BCC7965
    CAS No.:331001-62-8
  • PT 1

    Catalog No.:BCC7846
    CAS No.:331002-70-1
  • Stephavanine

    Catalog No.:BCN5253
    CAS No.:33116-33-5
  • BAM7

    Catalog No.:BCC1397
    CAS No.:331244-89-4
 

References on KH 7

Crystal structure of the first KH domain of human poly(C)-binding protein-2 in complex with a C-rich strand of human telomeric DNA at 1.7 A.[Pubmed:16186123]

J Biol Chem. 2005 Nov 18;280(46):38823-30.

Recognition of poly(C) DNA and RNA sequences in mammalian cells is achieved by a subfamily of the KH (hnRNP K homology) domain-containing proteins known as poly(C)-binding proteins (PCBPs). To reveal the molecular basis of poly(C) sequence recognition, we have determined the crystal structure, at 1.7-A resolution, of PCBP2 KH1 in complex with a 7-nucleotide DNA sequence (5'-AACCCTA-3') corresponding to one repeat of the human C-rich strand telomeric DNA. The protein-DNA interaction is mediated by the combination of several stabilizing forces including hydrogen bonding, electrostatic interactions, van der Waals contacts, and shape complementarities. Specific recognition of the three cytosine residues is realized by a dense network of hydrogen bonds involving the side chains of two conserved lysines and one glutamic acid. The co-crystal structure also reveals a protein-protein dimerization interface of PCBP2 KH1 located on the opposite side of the protein from the DNA binding groove. Numerous stabilizing protein-protein interactions, including hydrophobic contacts, stacking of aromatic side chains, and a large number of hydrogen bonds, indicate that the protein-protein interaction interface is most likely genuine. Interaction of PCBP2 KH1 with the C-rich strand of human telomeric DNA suggests that PCBPs may participate in mechanisms involved in the regulation of telomere/telomerase functions.

Soluble adenylyl cyclase controls mitochondria-dependent apoptosis in coronary endothelial cells.[Pubmed:19336406]

J Biol Chem. 2009 May 29;284(22):14760-8.

The cAMP signaling pathway plays an essential role in modulating the apoptotic response to various stress stimuli. Until now, it was attributed exclusively to the activity of the G-protein-responsive transmembrane adenylyl cyclase. In addition to transmembrane AC, mammalian cells possess a second source of cAMP, the ubiquitously expressed soluble adenylyl cyclase (sAC). However, the role of this cyclase in apoptosis was unknown. A mitochondrial localization of this cyclase has recently been demonstrated, which led us to the hypothesis that sAC may play a role in apoptosis through modulation of mitochondria-dependent apoptosis. To prove this hypothesis, apoptosis was induced by simulated in vitro ischemia or by acidosis, which is an important component of ischemia. Suppression of sAC activity with the selective inhibitor KH7 or sAC knockdown by small interfering RNA transfection abolished endothelial apoptosis. Furthermore, pharmacological inhibition or knockdown of protein kinase A, an important cAMP target, demonstrated a significant anti-apoptotic effect. Analysis of the underlying mechanisms revealed (i) the translocation of sAC to mitochondria under acidic stress and (ii) activation of the mitochondrial pathway of apoptosis, i.e. cytochrome c release and caspase-9 cleavage. sAC inhibition or knockdown abolished the activation of the mitochondrial pathway of apoptosis. Analysis of mitochondrial co-localization of Bcl-2 family proteins demonstrated sAC- and protein kinase A-dependent translocation of Bax to mitochondria. Taken together, these results suggest the important role of sAC in modulating the mitochondria-dependent pathway of apoptosis in endothelial cells.

Soluble adenylyl cyclase mediates nerve growth factor-induced activation of Rap1.[Pubmed:16627466]

J Biol Chem. 2006 Jun 23;281(25):17253-8.

Nerve growth factor (NGF) and the ubiquitous second messenger cyclic AMP (cAMP) are both implicated in neuronal differentiation. Multiple studies indicate that NGF signals to at least a subset of its targets via cAMP, but the link between NGF and cAMP has remained elusive. Here, we have described the use of small molecule inhibitors to differentiate between the two known sources of cAMP in mammalian cells, bicarbonate- and calcium-responsive soluble adenylyl cyclase (sAC) and G protein-regulated transmembrane adenylyl cyclases. These inhibitors, along with sAC-specific small interfering RNA, reveal that sAC is uniquely responsible for the NGF-elicited rise in cAMP and is essential for the NGF-induced activation of the small G protein Rap1 in PC12 cells. In contrast and as expected, transmembrane adenylyl cyclase-generated cAMP is responsible for Rap1 activation by the G protein-coupled receptor ligand PACAP (pituitary adenylyl cyclase-activating peptide). These results identify sAC as a mediator of NGF signaling and reveal the existence of distinct pathways leading to cAMP-dependent signal transduction.

Description

KH7 is a soluble adenylyl cyclase (sAC)-specific inhibitor, with IC50s of 3-10 μM toward both recombinant purified human sACt protein and heterologously expressed sACt in cellular assays. KH7 is also a cAMP inhibitor.

Keywords:

KH 7,330676-02-3,Natural Products,Adenylate cyclase, buy KH 7 , KH 7 supplier , purchase KH 7 , KH 7 cost , KH 7 manufacturer , order KH 7 , high purity KH 7

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: